821 related articles for article (PubMed ID: 11399701)
1. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the level of urinary cysteinyl leukotriene E4 in diagnosis of bronchopulmonary dysplasia in premature infants].
Jin R; Lu HY; Luo YY; Xu YX; Hu YH; Chen XQ
Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):703-7. PubMed ID: 27596087
[TBL] [Abstract][Full Text] [Related]
3. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia.
Joung KE; Kim HS; Lee J; Shim GH; Choi CW; Kim EK; Kim BI; Choi JH
Free Radic Res; 2011 Sep; 45(9):1024-32. PubMed ID: 21651454
[TBL] [Abstract][Full Text] [Related]
4. [Airway resistance and urinary LTE4 in children with bronchopulmonary dysplasia. Preliminary report].
Vargas MH; Ojeda-Luna NG; Furuya ME; Arreola-Ramírez JL; Zúñiga-Vázquez G
Rev Invest Clin; 2010; 62(1):15-22. PubMed ID: 20415055
[TBL] [Abstract][Full Text] [Related]
5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
6. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
8. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
9. [Frequency, severity and risk factors for bronchopulmonary dysplasia among very low birth weight premature infants admitted in the NICU of the University Obstetrics and Gynecology Hospital, Sofia].
Vakrilova L; Slancheva B; Hitrova S; Popivanova A; Emilova Z; Yarakova N
Akush Ginekol (Sofiia); 2013; 52(1):21-9. PubMed ID: 23805457
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological factors involved in the development of bronchopulmonary dysplasia in very low birth-weight preterm infants.
Lardón-Fernández M; Uberos J; Molina-Oya M; Narbona-López E
Minerva Pediatr; 2017 Feb; 69(1):42-49. PubMed ID: 25715027
[TBL] [Abstract][Full Text] [Related]
11. Urinary β2-microglobulin and bronchopulmonary dysplasia: Trends in preterm infants.
Shima Y; Kumasaka S; Nishimaki S
Pediatr Int; 2017 Nov; 59(11):1169-1173. PubMed ID: 28833913
[TBL] [Abstract][Full Text] [Related]
12. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
[TBL] [Abstract][Full Text] [Related]
13. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants.
Balena-Borneman J; Ambalavanan N; Tiwari HK; Griffin RL; Halloran B; Askenazi D
Pediatr Res; 2017 Mar; 81(3):519-525. PubMed ID: 27893721
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease.
Fanos V; Pintus MC; Lussu M; Atzori L; Noto A; Stronati M; Guimaraes H; Marcialis MA; Rocha G; Moretti C; Papoff P; Lacerenza S; Puddu S; Giuffrè M; Serraino F; Mussap M; Corsello G
J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():39-45. PubMed ID: 25284176
[TBL] [Abstract][Full Text] [Related]
16. Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants.
Zhou D; Shi F; Xiong Y; Zhou M; Wan H; Liu H
Eur J Pediatr; 2019 Jan; 178(1):81-87. PubMed ID: 30324231
[TBL] [Abstract][Full Text] [Related]
17. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
[TBL] [Abstract][Full Text] [Related]
18. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
[TBL] [Abstract][Full Text] [Related]
19. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
Nyp MF; Taylor JB; Norberg M; Truog WE
Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
[TBL] [Abstract][Full Text] [Related]
20. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
